IIM
RCKT icon

INTECH Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

INTECH Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.1K Sell
23,123
-3,788
-14% -$12.6K ﹤0.01% 1983
2026
Q1 		$96.3K Sell
26,911
-13,816
-34% -$54.9K ﹤0.01% 1899
2025
Q4 		$143K Hold
40,727
– – ﹤0.01% 2085
2025
Q3 		$133K Sell
40,727
-9,263
-19% -$29.2K ﹤0.01% 2185
2025
Q2 		$122K Buy
49,990
+1,272
+3% +$6.44K ﹤0.01% 2240
2025
Q1 		$325K Buy
48,718
+5,477
+13% +$54.1K ﹤0.01% 1842
2024
Q4 		$544K Buy
43,241
+14,686
+51% +$221K 0.01% 1516
2024
Q3 		$527K Buy
+28,555
New +$585K 0.01% 1198

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

INTECH Investment Management's RCKT Position: Q2 2026 in Review

INTECH Investment Management reduced its Rocket Pharmaceuticals (RCKT) stake by 14% in Q2 2026, selling an estimated $12.6K and leaving 23,123 shares worth $79.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

INTECH Investment Management first reported a position in RCKT in Q3 2024 and has held it in 8 quarters since. The position peaked at $544K in Q4 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • INTECH Investment Management held 23,123 shares of Rocket Pharmaceuticals worth $79.1K as of Q2 2026.
  • INTECH Investment Management sold 3,788 Rocket Pharmaceuticals shares in Q2 2026, an estimated $12.6K.
  • Rocket Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1983 holding.
  • INTECH Investment Management first reported a position in Rocket Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Rocket Pharmaceuticals position peaked at $544K in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.